Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  BioPharma Credit PLC    BPCR   GB00BDGKMY29

BIOPHARMA CREDIT PLC

(BPCR)
  Report
Delayed Quote. Delayed London Stock Exchange - 01/27 11:35:16 am
0.99 USD   -0.60%
2020BioPharma Credit to Lend Additional $75 Million to Epizyme
MT
2020BIOPHARMA CREDIT PLC : half-yearly earnings release
2020BIOPHARMA CREDIT : Change of AGM Venue
PU
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/21/2021 01/22/2021 01/25/2021 01/26/2021 01/27/2021 Date
1.005(c) 1(c) 0.996(c) 0.996(c) 0.99 Last
494 843 1 043 077 1 190 247 588 744 2 060 859 Volume
0.00% -0.50% -0.40% 0.00% -0.60% Change
More quotes
Financials (USD)
Sales 2018 97,3 M - -
Net income 2018 70,1 M - -
Net cash position 2018 364 M - -
P/E ratio 2018 15,0x
Yield 2018 6,19%
Sales 2019 151 M - -
Net income 2019 122 M - -
Net cash position 2019 297 M - -
P/E ratio 2019 11,5x
Yield 2019 6,86%
Capitalization 1 360 M 1 360 M -
EV / Sales 2018 11,3x
EV / Sales 2019 7,32x
Nbr of Employees -
Free-Float 87,6%
More Financials
Company
BioPharma Credit Plc is a closed-ended investment company. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company may acquire debt assets from a company operating in the life sciences industry or an entity other than a life sciences company, which directly or indirectly... 
Sector
Closed End Funds
Calendar
03/10Earnings Release
More about the company
All news about BIOPHARMA CREDIT PLC
2020BioPharma Credit to Lend Additional $75 Million to Epizyme
MT
2020BIOPHARMA CREDIT PLC : half-yearly earnings release
2020BIOPHARMA CREDIT : Change of AGM Venue
PU
2020BIOPHARMA CREDIT : Notice of AGM
PU
2020BIOPHARMA CREDIT : New credit facility
PU
2020BIOPHARMA CREDIT : Dividend Declaration
PU
2020BIOPHARMA CREDIT : Date of Annual General Meeting
PU
2020REPLACEMENT : Annual Financial Report
PU
2020BIOPHARMA CREDIT PLC : annual earnings release
2020BIOPHARMA CREDIT : Notice of Full Year Results
PU
2020BIOPHARMA CREDIT : New investment
PU
2019BIOPHARMA CREDIT : New Investment
PU
2019BIOPHARMA CREDIT : New Investment
PU
2019BIOPHARMA CREDIT PLC - CORRECTION : New Investment
PU
2019BIOPHARMA CREDIT : New Investment
PU
More news
News in other languages on BIOPHARMA CREDIT PLC
2020BIOPHARMA CREDIT PLC : Veröffentlichung des Halbjahresergebnisses
2020BIOPHARMA CREDIT PLC : publication des résultats semestriels
2020BIOPHARMA CREDIT PLC : publication des résultats annuels
2020BIOPHARMA CREDIT PLC : Veröffentlichung des Jahresergebnisses
More news
Chart BIOPHARMA CREDIT PLC
Duration : Period :
BioPharma Credit PLC Technical Analysis Chart | BPCR | GB00BDGKMY29 | MarketScreener
Technical analysis trends BIOPHARMA CREDIT PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price
Last Close Price 0,99 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
Managers and Directors
NameTitle
Duncan William Allan Budge Independent Non-Executive Director
Colin Bond Independent Non-Executive Director
Harry Abraham Hyman Senior Independent Director
Rolf Kristian Soderstrom Non-Executive Director
Sector and Competitors